• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

根治性肝切除术后肝细胞癌肝外复发的预测因素。

Predictors of extrahepatic recurrence after curative hepatectomy for hepatocellular carcinoma.

机构信息

Department of Surgery and Science, Graduate School of Medicine, Kyushu University, Fukuoka, Japan.

出版信息

Ann Surg Oncol. 2010 Oct;17(10):2740-6. doi: 10.1245/s10434-010-1076-2. Epub 2010 Apr 22.

DOI:10.1245/s10434-010-1076-2
PMID:20411432
Abstract

BACKGROUND

The aim of this study was to elucidate the predictors of extrahepatic hepatocellular carcinoma (HCC) recurrence after hepatectomy.

MATERIALS AND METHODS

A cohort of 252 patients with HCC who underwent hepatectomy following a recurrence were reviewed. The patients were categorized into 2 groups according to the pattern of their initial recurrence. Clinicopathological and survival data were compared between the groups.

RESULTS

Of the 252 patients, 218 had intrahepatic recurrence (IHR) (86.5%) and 34 had extrahepatic recurrence (EHR) (13.5%) as their initial recurrence. The mean duration of time until the initial recurrence after hepatectomy of the EHR and IHR groups was 1.8 and 2.2 years, respectively. The rate of recurrence within 6 months after hepatectomy of EHR and IHR groups was 35.3 and 14.2%, respectively (P = .002). The 3-, 5-, and 10-year cumulative survival rates of EHR group were 60.3, 24.0, and 6.0%, respectively, which were significantly lower than that of IHR group (74.5, 57.7, and 23.1%, P = .004). A multivariate analysis showed that blood loss during surgery and microscopic hepatic vein invasion remained as independent risk factors for increased EHR after hepatectomy for HCC. Furthermore, the combination of these 2 independent factors showed a significant association with the EHR.

CONCLUSIONS

EHR of HCC was associated with early recurrence and a poor survival after a hepatectomy. The combination of 2 independent factors for EHR, the presence of microscopic hepatic vein invasion and the blood loss during surgery, may be useful for predicting the risk for occurrence of EHR during the follow-up period.

摘要

背景

本研究旨在阐明肝癌(HCC)切除术后肝外 HCC 复发的预测因素。

材料与方法

回顾性分析了 252 例 HCC 患者行肝切除术后复发的病例。根据初始复发模式将患者分为两组。比较两组的临床病理和生存数据。

结果

在 252 例患者中,218 例(86.5%)为肝内复发(IHR),34 例(13.5%)为肝外复发(EHR)。EHR 和 IHR 组患者肝切除术后首次复发的平均时间分别为 1.8 年和 2.2 年。EHR 和 IHR 组患者肝切除术后 6 个月内的复发率分别为 35.3%和 14.2%(P=0.002)。EHR 组的 3、5 和 10 年累积生存率分别为 60.3%、24.0%和 6.0%,明显低于 IHR 组(74.5%、57.7%和 23.1%,P=0.004)。多因素分析显示,手术中失血量和镜下肝静脉侵犯是 HCC 肝切除术后 EHR 增加的独立危险因素。此外,这两个独立因素的结合与 EHR 有显著相关性。

结论

EHR 与 HCC 肝切除术后早期复发和生存不良有关。EHR 的 2 个独立因素(镜下肝静脉侵犯和手术中失血量)的组合可能有助于预测随访期间 EHR 的发生风险。

相似文献

1
Predictors of extrahepatic recurrence after curative hepatectomy for hepatocellular carcinoma.根治性肝切除术后肝细胞癌肝外复发的预测因素。
Ann Surg Oncol. 2010 Oct;17(10):2740-6. doi: 10.1245/s10434-010-1076-2. Epub 2010 Apr 22.
2
Treatment for extrahepatic metastasis of hepatocellular carcinoma following successful hepatic resection.肝切除成功后肝细胞癌肝外转移的治疗
Hepatogastroenterology. 1999 Sep-Oct;46(29):2931-4.
3
Long-term survival and prognostic factors after pulmonary metastasectomy in hepatocellular carcinoma.肝细胞癌肺转移瘤切除术后的长期生存和预后因素。
Ann Surg Oncol. 2010 Oct;17(10):2795-801. doi: 10.1245/s10434-010-1073-5. Epub 2010 Jun 2.
4
Clinicopathological factors and long-term outcome comparing between lung and peritoneal metastasectomy after hepatectomy for hepatocellular carcinoma in a tertiary institution.三级医疗机构中肝细胞癌肝切除术后肺和腹膜转移瘤切除术的临床病理因素及长期预后比较
Surgery. 2015 Apr;157(4):645-53. doi: 10.1016/j.surg.2014.07.024. Epub 2014 Nov 4.
5
Prolonged survival in selected patients following surgical resection for pulmonary metastasis from hepatocellular carcinoma.肝细胞癌肺转移患者手术切除后部分患者的长期生存情况。
Br J Surg. 1998 Sep;85(9):1198-200. doi: 10.1046/j.1365-2168.1998.00846.x.
6
Liver resection for metastatic colorectal cancer in patients with concurrent extrahepatic disease: results in 127 patients treated at a single center.同期合并肝外疾病的转移性结直肠癌患者的肝切除术:单中心127例患者的治疗结果
Ann Surg Oncol. 2009 Aug;16(8):2138-46. doi: 10.1245/s10434-009-0521-6. Epub 2009 Jun 3.
7
[Clinical factors affecting prognosis of small hepatocellular carcinoma after hepatectomy].[影响小肝细胞癌肝切除术后预后的临床因素]
Zhonghua Zhong Liu Za Zhi. 1994 May;16(3):225-7.
8
[Prognostic factors and outcome in patients with intrahepatic recurrence after hepatectomy for hepatocellular carcinoma].[肝细胞癌肝切除术后肝内复发患者的预后因素及结局]
Zhonghua Zhong Liu Za Zhi. 2009 Aug;31(8):612-6.
9
Outcomes of patients with spontaneous rupture of hepatocellular carcinoma.肝细胞癌自发性破裂患者的预后。
Hepatogastroenterology. 2011 Jan-Feb;58(105):99-102.
10
Surgical treatment of hepatocellular carcinoma beyond Milan criteria. Results of liver resection, salvage transplantation, and primary liver transplantation.米兰标准以外的肝细胞癌的外科治疗。肝切除、挽救性移植和原位肝移植的结果。
Ann Surg Oncol. 2008 May;15(5):1383-91. doi: 10.1245/s10434-008-9851-z. Epub 2008 Mar 5.

引用本文的文献

1
Lysyl oxidase as a potential biomarker of lung recurrence after hepatectomy in hepatocellular carcinoma.赖氨酰氧化酶作为肝细胞癌肝切除术后肺复发的潜在生物标志物。
Sci Rep. 2025 Aug 26;15(1):31465. doi: 10.1038/s41598-025-15474-y.
2
Extrahepatic Recurrence After Surgical Resection of Hepatocellular Carcinoma Without Intrahepatic Recurrence: A Multi-Institutional Observational Study.肝细胞癌手术切除后无肝内复发的肝外复发:一项多机构观察性研究
Cancers (Basel). 2025 Apr 23;17(9):1417. doi: 10.3390/cancers17091417.
3
Prognostic comparison between pulmonary metastasectomy and combination immunotherapy with targeted molecular therapies for advanced hepatocellular carcinoma with pulmonary metastasis: A propensity score matching analysis.
肺转移瘤切除术与联合免疫治疗及靶向分子治疗对晚期肺转移肝细胞癌的预后比较:倾向评分匹配分析
Liver Res. 2025 Jan 30;9(1):29-35. doi: 10.1016/j.livres.2025.01.006. eCollection 2025 Mar.
4
Surgical resection of late extrahepatic metastasis of hepatocellular carcinoma 11 years after initial diagnosis: case report and literature review.肝细胞癌初次诊断11年后肝外晚期转移灶的手术切除:病例报告及文献复习
J Surg Case Rep. 2024 Oct 8;2024(10):rjae632. doi: 10.1093/jscr/rjae632. eCollection 2024 Oct.
5
Evaluation of prognostic efficacy of liver immune status index in predicting postoperative outcomes in hepatocellular carcinoma patients: A multi-institutional retrospective study.评估肝脏免疫状态指数对预测肝癌患者术后结局的预后效能:一项多机构回顾性研究。
J Hepatobiliary Pancreat Sci. 2024 Nov;31(11):798-808. doi: 10.1002/jhbp.12070. Epub 2024 Sep 23.
6
Impact of a new liver immune status index among patients with hepatocellular carcinoma after initial hepatectomy.一种新的肝脏免疫状态指数对肝细胞癌患者初次肝切除术后的影响。
Ann Gastroenterol Surg. 2023 May 29;7(6):987-996. doi: 10.1002/ags3.12702. eCollection 2023 Nov.
7
Consensus on the tertiary prevention of primary liver cancer.原发性肝癌三级预防共识。
Hepatol Int. 2023 Oct;17(5):1057-1071. doi: 10.1007/s12072-023-10549-2. Epub 2023 Jun 27.
8
Nomograms for postsurgical extrahepatic recurrence prediction of hepatocellular carcinoma based on presurgical circulating tumor cell status and clinicopathological factors.基于术前循环肿瘤细胞状态和临床病理因素的肝癌术后肝外复发预测的列线图。
Cancer Med. 2023 Jul;12(14):15065-15078. doi: 10.1002/cam4.6178. Epub 2023 Jun 20.
9
Viral Status and Treatment Efficacy in Recurrent Hepatocellular Carcinoma After Primary Resection.原发性肝癌切除术后复发患者的病毒状态与治疗效果。
J Gastrointest Surg. 2023 Aug;27(8):1594-1610. doi: 10.1007/s11605-023-05691-z. Epub 2023 May 25.
10
Early extrahepatic recurrence as a pivotal factor for survival after hepatocellular carcinoma resection: A 15-year observational study.早期肝外复发是肝癌切除术后生存的关键因素:一项 15 年观察性研究。
World J Gastroenterol. 2022 Sep 28;28(36):5351-5363. doi: 10.3748/wjg.v28.i36.5351.